Change search
Refine search result
1 - 7 of 7
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • apa.csl
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the Create feeds function.
  • 1.
    Edebol, Hanna
    Karlstad University, Faculty of Economic Sciences, Communication and IT, Department of Psychology.
    Global Assessment of Attention Deficit Hyperactivity Disorder: Examining Objective Measures of Hyperactivity, Impulsivity and Inattention in Adults2012Doctoral thesis, comprehensive summary (Other academic)
    Abstract [en]

    The aim of this thesis is to examine objective laboratory measures of Attention Deficit Hyperactivity Disorder (ADHD) in adult persons and to develop measures for diagnosis and treatment using a psychometric instrument called the Quantified Behavior Test Plus. The instrument objectively quantifies cardinal symptom manifestations in adult ADHD using motion tracking devices and continuous performance testing. Paper I-IV suggest that ADHD predisposes adult persons to perform poorer on continuous performance tasks and to have higher levels of motor activity while performing these tasks as compared to other clinical as well as non-clinical groups. Performance by adults with ADHD is normalized following stimulant treatment which implicates therapeutic effects and measures of response to treatment and remission for ADHD is suggested.

    Paper I concludes that the psychometric instrument needs to be calibrated with regard to adult ADHD and emphasizes the importance of a composite measure for the disorder. Paper II generates two new measures, the Weighed Core Symptom scale (WCS) - a composite measure of adult ADHD ranging from 0 to 100, and Prediction of ADHD (PADHD) - a categorical variable of the diagnostic status with good predictive power. A majority of participants with ADHD has low points on WCS (indicating high levels of symptoms) and a majority of non-ADHD normative participants has high points on WCS (indicating low levels of symptoms). Paper III examines WCS and PADHD among complex clinical groups with shared symptoms vis-à-vis ADHD. Here, findings from Paper II are replicated since participants with ADHD present the highest level of global symptoms, followed by participants with bipolar II disorder and borderline personality disorder, participant with diconfirmed ADHD and finally, non-clinical participants has the lowest level of global symptoms. In Paper IV, the measures are proposed as indications of response to treatment and remission after titration with stimulant treatment and WCS indicates response to small changes in dose level.

    The major findings of the present thesis may be summarized as the construction of two new objective measures for ADHD in adult persons with practical implications for diagnosis and treatment. Hyperactivity is the most specific marker of ADHD in both men and women, followed by the cognitive markers of inattention and impulsivity. The composite measure, WCS, quantifies the global amount of ADHD symptoms and provides the most sensitive measure for the disorder. PADHD and WCS may not replace a thorough neuropsychiatric assessment and further studies promoting diagnostic subtype stratification is suggested. Future studies may want to consider these measures in outcome-based investigations of treatment efficacy as well as in the study of neuropsychological endophenotypes. Practical implications include clinical strategies to enhance objectivity during assessment as well as optimizing beneficial effects of treatment and attaining remission.

     

     

    Download full text (pdf)
    fulltext
  • 2.
    Edebol, Hanna
    Karlstad University, Faculty of Economic Sciences, Communication and IT, Department of Psychology.
    Measuring Cardinal Symptoms of Attention Deficit Hyperactivity Disorder in Adults: Examining objective measures of hyperactivity, impulsivity, and inattention2011Licentiate thesis, comprehensive summary (Other academic)
    Abstract [en]

    The purpose of this licentiate thesis is to examine measures of ADHD in adult persons. An instrument that reports objective measures of cardinal symptoms of ADHD in adult persons is used for this purpose. The instrument is called the Quantified Behavior Test Plus and records motor activity by means of an infrared motion tracking system and cognitive deficits with a continuous performance test. Paper I investigates sensitivity and specificity for the test with regard to ADHD in a clinic-referred sample. When the test was compared to clinical assessments, results yielded 83 % sensitivity and 57 % specificity. The high level of comorbid psychiatric disorders motivates continuous search for a composite measure of ADHD cardinal symptoms and better understanding of normative behavior in healthy participants. In Paper II, a composite measure of ADHD called the Weighed Core Symptom scale (WCS) is developed. WCS integrates measures of ADHD cardinal symptoms on a ten point scale. A majority of participants with ADHD has low points on the scale (indicating high levels of symptoms) and a majority of healthy normative participants has high points on the scale (indicating low levels of symptoms). Levels of sensitivity and specificity for the test were examined with a measure called Prediction of ADHD (PADHD), and results yielded 86 % sensitivity and 83 % specificity. The measures developed in Paper II are tentative and needs to be tested in further studies in order to better understand behavior manifestations of ADHD in adult persons.

  • 3.
    Edebol, Hanna
    et al.
    Karlstad University, Faculty of Economic Sciences, Communication and IT (discontinued), Department of Psychology.
    Helldin, Lars
    NU health care.
    Holmberg, Ebba
    NU health care.
    Gustafsson, Stig-Arne
    NU health care.
    Norlander, Torsten
    Karlstad University, Faculty of Economic Sciences, Communication and IT (discontinued), Department of Psychology.
    In search for objective measures of hyperactivity, impulsivity and inattention in adult attention deficit hyperactivity disorder using the Quantified Behaviour Test Plus2011In: Europe's Journal of Psychology, E-ISSN 1841-0413, Vol. 7, no 3, p. 443-457Article in journal (Refereed)
    Abstract [en]

    Clinical assessment tools for adult ADHD such as rating scales, interviews and behavior observations are often based on subjective judgments which enhance the risk of overlooking or misinterpreting symptoms. In search for objective measures of adult ADHD, the present study investigated levels of sensitivity and specificity for the Quantified Behavior Test Plus, QbTest-Plus, in adult patients (N = 19) awaiting clinical assessment for ADHD. QbTest-Plus report objective measures of ADHD core symptoms using an infrared motion tracking system and a continuous performance test. The measures were collected and evaluated previous to clinical assessment and compared regarding the diagnosis of ADHD. Sensitivity for detecting ADHD with QbTest-Plus was 83 % and specificity was 57 %. The results, possibly affected by confounding factors, suggest further examination of calibrated and objective measure for the QbTest-Plus with regard to ADHD in adults.

     

  • 4.
    Edebol, Hanna
    et al.
    Karlstad University, Faculty of Economic Sciences, Communication and IT, Department of Psychology.
    Helldin, Lars
    Department of Psychiatry, NU-health care, Trollhättan, Sweden.
    Norlander, Torsten
    Evidence Research and Development Center Göteborg Sweden.
    Measuring Adult Attention Deficit Hyperactivity Disorder using the Quantified Behaviour Test Plus2013In: PsyCh Journal, ISSN 2046-0260, Vol. 2, no 1, p. 48-62Article in journal (Refereed)
    Abstract [en]

    Attention Deficit Hyperactivity Disorder, ADHD, occurs in about 5 % of the adult population and includes cardinal symptoms of hyperactivity, inattention, and impulsivity that may be difficult to identify with clinical routine methods. Continuous performance tests are objective measures of inattention and impulsivity that, combined with objective measures of motor activity, facilitate identification of ADHD among adults. The aim of the present study was to examine sensitivity, specificity and a composite measure of ADHD using objective measures of the ADHD-cardinal symptoms in adult participants with ADHD and non-ADHD normative participants.

    Cardinal symptoms were measured in 55 participants having ADHD, 202 non-ADHD normative participants, as well as 84 ADHD normative participants using the Quantified Behavior Test Plus, QbTest-Plus. This test measures inattention and impulsivity with a continuous performance test and hyperactivity with a motion tracking system.

    A predictive variable for detection of ADHD called Prediction of ADHD, PADHD, yielded 86 % sensitivity and 83 % specificity. A composite measure of ADHD cardinal symptoms was developed with a Weighed Core Symptoms scale, WCS, that indicates the total amount of ADHD symptoms on a numeric scale from 0 to 100.

    The total amount of ADHD symptoms was measured on a scale and predicted with the categorical variable in a majority of the cases in the present study. Further studies are needed in order to confirm the results with regard to additional clinical and normative samples. Careful consideration of potential gender and diagnostic subtype differences are noteworthy aspects for future examinations of the new instruments.

  • 5.
    Edebol, Hanna
    et al.
    Karlstad University, Faculty of Economic Sciences, Communication and IT (discontinued), Department of Psychology.
    Helldin, Lars
    The NU-Health Care, Trollhättan, Sweden.
    Norlander, Torsten
    Karlstad University, Faculty of Economic Sciences, Communication and IT (discontinued), Department of Psychology. Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
    Objective measures of behavior manifestations in adult ADHD and differentiation from participants with Bipolar II disorder, Borderline personality disorder, participants with disconfirmed ADHD as well as Normative participants2012In: Clinical Practice and Epidemiology in Mental Health, E-ISSN 1745-0179, Vol. 8, p. 134-143Article in journal (Refereed)
    Abstract [en]

    Background: The present study evaluated two psychometric instruments derived from the objective measurement of adult ADHD using the Quantified Behavior Test Plus. The instruments were examined in ADHD versus a clinical group with overlapping symptoms including borderline personality disorder and bipolar II disorder, and another clinical group with participants assessed for but disconfirmed a diagnosis of ADHD as well as adult normative participants.

    Methods: The Quantified Behavior Test Plus includes Continuous Performance Testing and a Motion Tracking System with parameters related to attention and activity operationalized as the cardinal symptoms of ADHD and then summarized into a Weighed Core Symptoms scale with ten cut-points ranging from 0 to 100. A categorical predictor variable called Prediction of ADHD was used to examine the levels of sensitivity and specificity for the Quantified Behavior Test Plus with regard to ADHD.

    Results: The Weighed Core Symptoms scale separated ADHD and normative participants from each other as well as from the two clinical reference groups. The scale reported highest levels of core symptoms in the ADHD group and the lowest level of core symptoms in the normative group. Analyses with Prediction of ADHD yielded 85 % specificity for the normative group, 87 % sensitivity for the ADHD group, 36 % sensitivity for the bipolar II and borderline group and 41 % sensitivity for the group with a disconfirmed diagnosis of ADHD.

    Conclusions: The Weighed Core Symptoms scale facilitated objective assessment of adult ADHD insofar that the ADHD group presented more core symptoms than the other two clinical groups and the normative group. Sensitivity for the Quantified Behavior Test Plus was lower in complex clinical groups with Bipolar II disorder, Borderline disorder and in patients with a disconfirmed diagnosis of ADHD. The psychometric instruments may be further evaluated with regard to well-documented and effective treatment programs for ADHD core symptoms.

  • 6.
    Edebol, Hanna
    et al.
    Örebro University.
    Helldin, Lars
    Department of Psychiatry, the NU-Health Care, Trollhättan.
    Norlander, Torsten
    Karolinska Institutet; Evidens Research and Development Center, Göteborg.
    The Weighed Core Symptom Scale and Prediction of ADHD in adults: Objective Measures of Remission and Response to Treatment with Methylphenidate2013In: Clinical Practice and Epidemiology in Mental Health, E-ISSN 1745-0179, Vol. 9, p. 171-179Article in journal (Refereed)
    Abstract [en]

    Objective: Two measures of the response rate and the optimal treatment response for adult ADHD were evaluated using methylphenidate. The hypotheses were that Prediction of ADHD (PADHD) defines remission, the Weighed Core Symptom (WCS) scale registers direct effects of medication and that WCS may indicate the optimal dose level during titration.

    Design: PADHD and WCS were analyzed at baseline and after intake of low doses of either short-acting or modifiedrelease formulations of methylphenidate, MPH (Study I), during titration with modified-release formulations of MPH (18/27, 36, 54, 72 mg) and at three months follow-up (Study II).

    Patients: Study I consisted of 63 participants (32 females) and Study II consisted of 10 participants (6 females) diagnosed with ADHD and who was to start with treatment.

    Outcome measures: Prediction of ADHD (PADHD) indicates the occurrence of ADHD (No, Yes) and the Weighed Core Symptom scale (WCS) quantifies ADHD from 0 to 100 (max-min).

    Results: The number of clinical cases of ADHD decreased after methylphenidate treatment according to PADHD. WCS increased (p < 0.001) from 9.75 (SD = 12.27) to 47.50 (SD = 29.75) with about 10 mg of methylphenidate (N = 63). During titration, symptoms improved after 18/27 mg and 36 mg of methylphenidate and baseline-follow up comparisons showed WCS increments (p = 0.005) from 31.00 (N = 10, SD = 26.85) to 69.00 (N = 10, SD = 22.34).

    Conclusions: PADHD defined remission and WCS measured therapeutic effects of methylphenidate in adult ADHD.

    Download full text (pdf)
    fulltext
  • 7.
    Kjellgren, Anette
    et al.
    Karlstad University, Faculty of Arts and Social Sciences (starting 2013), Department of Social and Psychological Studies (from 2013).
    Edebol, Hanna
    Nutrition Gut Brain Interactions Research Centre, Örebro University, Örebro, Sweden.
    Nordén, Tommy
    Evidens Research and Development Center, Göteborg, Sweden.
    Norlander, Torsten
    Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
    Quality of Life with Flotation Therapy for a Person Diagnosed with Attention Deficit Disorder, Atypical Autism, PTSD, Anxiety and Depression2013In: Open Journal of Medical Psychology, ISSN 2165-9389, Vol. 2, no 3, p. 134-138Article in journal (Refereed)
    Abstract [en]

    The aim of this single-subject study was to report experiences from one and a half years of regular floating as described by a person with neuropsychiatric and mental health disorders. Floating, or Flotation Restricted Environmental Stimulation Technique, involves relaxation and sensory deprivation by means of resting in a tank with highly salted and body-tempered water. The subject, a 24-year-old woman diagnosed with attention deficit hyperactivity disorder, atypical autism, post-traumatic stress disorder, anxiety and depression floated regularly for one and a half years. Interviews regarding her experiences were analyzed and the main findings involved a subjective sense of improved quality of life, wellbeing and healthy behavior. There were no negative effects from treatment. Results suggest that floating may have beneficial therapeutic effects on mental health. Further studies that evaluate the efficacy and possible effects of floating with regard to mental health are needed.

    Download full text (pdf)
    quality of life
1 - 7 of 7
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • apa.csl
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf